Citations 0
January 9, 2002

Ramipril and Risk of Diabetes

Author Affiliations

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthor


Copyright 2002 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2002

JAMA. 2002;287(2):186-187. doi:10.1001/jama.287.2.186

To the Editor: Dr Yusuf and colleagues1 reported a reduction in the risk of developing diabetes during treatment with ramipril. However, examination of the data presented in Figure 1 reveals that the cumulative risk of developing diabetes in the placebo group at 2, 3, and 4 years of follow-up is approximately equal to the cumulative risk in the ramipril group at 3, 4, and 4.5 years, respectively. In other words, it appears that rather than preventing diabetes, treatment with ramipril only delays the recognition of diabetes by about 1 year.

First Page Preview View Large
First page PDF preview
First page PDF preview